SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-273138
Filing Date
2019-10-24
Accepted
2019-10-24 08:36:03
Documents
3
Period of Report
2019-10-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823026d8k.htm 8-K 20823
2 EX-99.1 d823026dex991.htm EX-99.1 23575
3 GRAPHIC g823026g1024112345173.jpg GRAPHIC 4921
  Complete submission text file 0001193125-19-273138.txt   52535
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37813 | Film No.: 191164879
SIC: 2834 Pharmaceutical Preparations